Home >> 2025 02
[165-169]Interpretation of Chinese experts' consensus on the whole-course management of implantable venous access port in the upper arm of cancer patients
ZHOU Can,CHEN Wuke
2025 02 [Abstract](81)
[170-177]DADS down-regulated DJ-1 inhibition of human gastric cancer MGC803 cell invasion and epithelial-mesenchymal transformation via PTEN/Akt pathway
XIA Hong1,ZHOU Juan1,LIU Fang1,SU Jian2,SU Bo3,SU Qi1
2025 02 [Abstract](91)
[178-185]The expression level and biological function of DRG1 in hepatocellular carcinoma cells
ZHU Xuanhao1,DANG Yuting1,LI Can2,BIAN Huijie2,LIU Zekun2
2025 02 [Abstract](90)
[186-193]Melatonin increases the sensitivity of esophageal cancer cells to paclitaxel by inhibiting the expression of ESCCAL-1
ZHANG Jing,ZHANG Yueli,GUAN Hongya,LIU Jia
2025 02 [Abstract](54)
[194-198]Preliminary study on the effect of intratumoral gram-negative bacteria on lung cancer cell death
ZHANG Huijie1，ZHAI Meng'en2，JIANG Jianli3，JING Lin3
2025 02 [Abstract](57)
[199-207]The expression of circular RNA circPRELID2 with coding function in colorectal cancer tissues and its effects on cell proliferation and apoptosis
SHENG Huan1,FU Dandan1,HU Xiaoyun1,2,FAN Yuxuan1,WANG Ziqing1,ZHANG Mingrong1,WU Ting1,ZHANG Yongzhen1,SUN Huimin1,WU Huizhe1,2
2025 02 [Abstract](44)
[208-217]Effect of exosomal circ-0001328 on gemcitabine resistance in gallbladder cancer cells by targeting miR-545-3p
CHEN Ping1,WU Jianchun1,YANG Zhen2,JIANG Shihao2,ZHOU Ning2
2025 02 [Abstract](47)
[218-225]Expression levels of serum VEGF-A and EFNA1 in patients with papillary thyroid carcinoma and their correlation with cervical lymph node metastasis
WANG Chun1,ZHANG Linlin2,ZHAO Hongjian2,XING Hao3,YIN Fengyan3,ZHANG Hui3,CAO Wenyuan1,LUO Xiaoting1,HE Qian1,XING Weijia1
2025 02 [Abstract](51)
[226-233]Correlation between tertiary lymphoid structures scores and class-switched memory B cells in breast cancer microenvironment and its effect on patients survival
ZHU Liangxiao1，DU Yiqiao2，WANG Wenhui2，JIANG Guangjie3，ZHANG Chao4,GAO Fenghou1
2025 02 [Abstract](46)
[234-240]Expression and significance of LncRNA Linc01305 from plasma extracellular vesicles in breast cancer
LIANG Li1,SHEN Jian2,PENG Huiyong3，ZHANG Lei1,ZHU Dongwei2
2025 02 [Abstract](41)
[241-248]Nutritional and inflammatory markers for predicting acute severe adverse events in patients with esophageal squamous cell carcinoma treated by radical radiotherapy and concurrent chemoradiotherapy
DENG Jie,YANG Bo,SUN Xiang
2025 02 [Abstract](47)
[249-254]Single hole thoracoscopic lobectomy in the treatment of lung cancer patients converted to thoracotomy:Influencing factors
FAN Yisong,WANG Rui
2025 02 [Abstract](38)
[255-262]The role of kappa/lambda light chain ratio in evaluating the efficacy of bortezomib in the treatment of patients with multiple myeloma
YANG Juanjuan,LI Xiaotong,DAI Suya
2025 02 [Abstract](40)
[263-268]Risk factors related to the death of patients with diffuse large B-cell lymphoma within one year and the construction of prediction model
LI Nana1，DING Binbin1，DONG Bai1，LI Zijian2
2025 02 [Abstract](43)
[269-274]Analysis of clinicopathological features and prognostic factors in 5 cases of primary ovarian goiter carcinoid
WEI Xin1，ZHANG Yanrui1,LU Xiangyu1，LIU Limin2
2025 02 [Abstract](45)
[275-280]Analysis of the effect of PD-1 inhibitor treatment on blood cell immune factors in patients with cervical malignancies
WEI Yongqiang,YANG Zhijun,ZHAO Bingbing,LI Zhuang,ZHOU Lu,LI Kuina,YANG Meng,HUANG Zhijiong
2025 02 [Abstract](37)
[281-287]Effect of propofol and remimazolam benzenesulfonate on intracranial pressure and quality of postoperative awakening in patients underwent laparoscopy surgeries with gynecological tumors
LENG Lin1，JIN Yeyuan2，HE Zongzhao2，ZHANG Lingmin3，LI Fugui2
2025 02 [Abstract](36)
[288-292]A radiomics model based on multi-phase contrast-enhanced CT for predicting HER2 expression in gastric cancer patients
SONG Tianjun1，2,XUE Bing3,HU Chunfeng2，4
2025 02 [Abstract](43)
[298-302]Research progress and future perspectives of gut microbiota in endocrine therapy for hormone receptor-positive breast cancer
YAO Peizhuo,FANG Biyun,LI Chaofan,JIA Yiwei,WEI Xinyu,ZHANG Shuqun
2025 02 [Abstract](65)
[303-310]Research progress on neoadjuvant immunotherapy for locally advanced head and neck squamous cell carcinoma
PU Shasha1,2,HU Yunfeng3,SHI Mei2
2025 02 [Abstract](52)
[311-315]Research progress of magnetic resonance imaging radiomics in the diagnosis and treatment of rectal cancer
SU Yexin1，ZHAO Hongyue2，LIU Pengfei1
2025 02 [Abstract](44)
[316-320]Research progress of immunotherapy for microsatellite instability gastric cancer
ZHANG Xin1,FANG Changxing2,YANG Min3,YAO Tian4,JIA Kai4,GUO Jiansheng4
2025 02 [Abstract](58)
[321-326]Research progress of CRISPR/Cas9 technology in endometrial cancer treatment
NIU Yimo，WANG Yuning,ZHANG Yi
2025 02 [Abstract](49)
[327-334]Advances of artificial intelligence in histological diagnosis of colorectal cancer and its precancerous lesions
WU Zhifeng1,2,3,YAO Liwen1,2,3,WU Lianlian1,2,3,ZENG Zhi4,YU Honggang1,2,3
2025 02 [Abstract](53)
[335-341]Key advances in anatomy and resection techniques of the caudate lobe of the liver
WANG Yunfeng1,WU Xiaobing2,JIANG Xiaoqing2
2025 02 [Abstract](56)
[342-348]Research progress of PANoptosis in tumor treatment
ZHENG Shuting1，LI Shanshan1，DU Xinyi1，FU Bo2
2025 02 [Abstract](65)